Resource Type

Journal Article 4

Year

2022 1

2021 1

2018 1

2008 1

Keywords

MYC 2

HDAC inhibitor 1

MAX 1

MLX 1

NOTCH1 1

T-cell acute lymphoblastic leukemia 1

c-Myc 1

cancer 1

chidamide 1

different 1

molecular mechanism 1

network 1

synthetic lethality 1

transcriptase-polymerase 1

transcription 1

transcription factor 1

ubiquitination 1

understood 1

undruggable 1

vehicle-treated 1

open ︾

Search scope:

排序: Display mode:

Targeting “undruggable” c-Myc protein by synthetic lethality

Chen Wang, Hui Fang, Jiawei Zhang, Ying Gu

Frontiers of Medicine 2021, Volume 15, Issue 4,   Pages 541-550 doi: 10.1007/s11684-020-0780-y

Abstract: This method provides a new avenue for targeting “undruggable” proteins, such as c-Myc.Here, we revisit current methods used to target c-Myc and discuss the important functional nodes relatedto c-Myc in non-oncogene addicted network, whose inhibition may cause a catastrophe for tumor cell destiny

Keywords: synthetic lethality     undruggable     transcription factor     c-Myc    

Chidamide inhibits the NOTCH1-MYC signaling axis in T-cell acute lymphoblastic leukemia

Frontiers of Medicine 2022, Volume 16, Issue 3,   Pages 442-458 doi: 10.1007/s11684-021-0877-y

Abstract: In particular, chidamide inhibits the NOTCH1-MYC signaling axis by down-regulating the level of the intracellularform of NOTCH1 (NICD1) as well as MYC, partly through their ubiquitination and degradation by the proteasome

Keywords: T-cell acute lymphoblastic leukemia     HDAC inhibitor     chidamide     NOTCH1     MYC     ubiquitination    

The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis

Patrick A. Carroll, Brian W. Freie, Haritha Mathsyaraja, Robert N. Eisenman

Frontiers of Medicine 2018, Volume 12, Issue 4,   Pages 412-425 doi: 10.1007/s11684-018-0650-z

Abstract: In this review we focus on the MYC network (also known as the MAX-MLX Network), a highly conserved super-familyImportantly the MYC network has been shown to be deeply involved in a broad spectrum of human and otherMoreover, oncogenic activation of MYC and/or loss of a MYC antagonist, results in an imbalance in the

Keywords: network     transcription     cancer     MYC     MAX     MLX    

Abnormal expression of c-Myc in human bronchial epithelial cells malignantly transformed by anti-BPDE

FU Juan, JIANG Yiguo, CHEN Xuemin

Frontiers of Medicine 2008, Volume 2, Issue 4,   Pages 380-385 doi: 10.1007/s11684-008-0073-3

Abstract: The levels of mRNA and protein of c-Myc were examined in the 16HBE-T and vehicle-treated control cellsLikewise, the expression of c-Myc protein was significantly enhanced as compared with those of the controlMoreover, the localization of c-Myc protein shows mainly nuclear staining in 16HBE-T.In conclusion, the abnormal expression of c-Myc was present in anti-BPDE malignantly transformed 16HBE

Keywords: transcriptase-polymerase     vehicle-treated     understood     molecular mechanism     different    

Title Author Date Type Operation

Targeting “undruggable” c-Myc protein by synthetic lethality

Chen Wang, Hui Fang, Jiawei Zhang, Ying Gu

Journal Article

Chidamide inhibits the NOTCH1-MYC signaling axis in T-cell acute lymphoblastic leukemia

Journal Article

The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis

Patrick A. Carroll, Brian W. Freie, Haritha Mathsyaraja, Robert N. Eisenman

Journal Article

Abnormal expression of c-Myc in human bronchial epithelial cells malignantly transformed by anti-BPDE

FU Juan, JIANG Yiguo, CHEN Xuemin

Journal Article